LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise and pioneering research in the field of coenzymes and NAD+, both parties share a common view and philosophy to develop and deliver the most advanced NAD-based therapeutics and supplement innovation and products, to those who seek a longer, healthier, and more vital life..

伦敦--（商业新闻短讯）--NADclinic Group和Bontac Bio Engineering（深圳）有限公司正式达成动态战略合作伙伴关系，共同关注全球健康和福祉的未来。通过协同利用他们在辅酶和NAD+领域的集体专业知识和开创性研究，双方拥有共同的观点和理念，为寻求更长，更健康，更有活力的生活的人开发和提供最先进的基于NAD的疗法，补充创新和产品。。

On 6 May 2024, Bontac Bio-Engineering (Shenzhen) Co., Ltd and NADclinic Group signed a partnership cooperation agreement, formalising their ambition to become deep strategic partners.

2024年5月6日，邦塔生物工程（深圳）有限公司与NADclinic集团签署了合作协议，正式确立了他们成为深度战略合作伙伴的愿望。

Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme central to metabolism that is found in all living cells. NAD+ is an essential coenzyme that converts glucose into cellular energy in the human body, supporting a healthier ageing process, driving metabolic function, supporting DNA repair, reducing inflammation, and decreasing our susceptibility to disease and chronic illness.

烟酰胺腺嘌呤二核苷酸（NAD+）是一种代谢中心的辅酶，存在于所有活细胞中。NAD+是一种必需的辅酶，可将葡萄糖转化为人体内的细胞能量，支持更健康的衰老过程，驱动代谢功能，支持DNA修复，减轻炎症，降低我们对疾病和慢性疾病的易感性。

NAD+ is necessary for over 500 critical enzymatic reactions in the body..

NAD+是体内500多种关键酶促反应所必需的。。

The partnership between NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd highlights their joint philosophy for elevating and emphasising the importance of global NAD+ research, and collectively developing innovative, science-backed methods to deliver optimised bioavailability and administration techniques to support improved patient outcomes.

NADclinic和Bontac Bio Engineering（深圳）有限公司之间的合作突出了他们的共同理念，即提升和强调全球NAD+研究的重要性，并共同开发创新的科学支持方法，以提供优化的生物利用度和给药技术，以支持改善患者预后。

The significant recent growth in the global NAD+ market is expected to increase exponentially over the coming years. The partnership between NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd ensures that both parties are at the forefront of this exciting growth trend in preventive health innovation, human performance, and longevity..

全球NAD+市场近期的显著增长预计将在未来几年呈指数增长。NADclinic Group和Bontac Bio Engineering（深圳）有限公司之间的合作关系确保了双方在预防性健康创新、人类绩效和寿命方面处于这一令人兴奋的增长趋势的最前沿。。

The collaboration generates excellent synergy by combining Bontac Bio-Engineering (Shenzhen) Co., Ltd’s coenzyme APIs, NAD+ raw materials, and expertise in NAD-based product development, with NADclinic’s expansive global footprint and pioneering R&D within the NAD+ therapy space. NADclinic supports the promotion of metabolism-boosting NAD+ products vital for human health optimisation and longevity.

该合作将邦塔克生物工程（深圳）有限公司的辅酶原料药、NAD+原材料和基于NAD的产品开发专业知识与NADClinice的广阔全球足迹和NAD+治疗领域的开创性研发相结合，产生了极好的协同作用。NADclinic支持促进新陈代谢的NAD+产品，这些产品对人类健康的优化和长寿至关重要。

The NADclinic brand, known globally for their innovative, forward-thinking approach and transformative IV protocols, therapeutics, and supplements, are equally enthusiastic about the collaboration and the opportunities that working closely with Bontac Bio-Engineering (Shenzhen) Co., Ltd offers for the future..

NADclinic品牌以其创新、前瞻性的思维方式和变革性的静脉注射方案、治疗方法和补充剂而闻名全球，同样热衷于与Bontac Bio Engineering（深圳）有限公司密切合作为未来提供的合作和机会。。

'At NADclinic, we are committed to continuing pioneering advancements in NAD+ therapeutics and nutraceuticals to empower individuals to live longer, healthier, more vibrant lives. NADclinic continues to be the benchmark brand in the NAD+ sector globally, and working closely with Bontac Bio-Engineering (Shenzhen) Co., Ltd will only amplify this.

“在NADclinic，我们致力于继续在NAD+治疗和营养保健方面取得开创性进展，以使个人能够活得更长，更健康，更有活力。NADclinic仍然是全球NAD+行业的基准品牌，与Bontac Bio Engineering（深圳）有限公司密切合作只会扩大这一点。

Partnering with Bontac Bio-Engineering (Shenzhen) Co., Ltd aligns perfectly with our own mission, allowing us to combine and consolidate our expertise and resources to deliver unparalleled solutions to our clients worldwide,' said Iain De Havilland, the Founder and CEO of NADclinic..

NADclinic创始人兼首席执行官伊恩·德哈维兰德（IainDeHavilland）表示，与邦塔生物工程（深圳）有限公司的合作完全符合我们自己的使命，使我们能够结合并巩固我们的专业知识和资源，为全球客户提供无与伦比的解决方案。。

'We are thrilled to join forces with NADclinic, a company that shares our commitment to excellence and innovation in the field of NAD+ therapy. Through this partnership, we aim to leverage our collective expertise to provide individuals around the world with access to the highest quality NAD+ products, supporting their journey towards improved health and vitality,' said Professor Zhang Qi, the Chief Scientist and Founder of Bontac Bio-Engineering (Shenzhen) Co., Ltd..

“我们很高兴能与NADclinic携手合作，NADclinic是一家致力于NAD+治疗领域卓越和创新的公司。邦塔克生物工程（深圳）有限公司首席科学家兼创始人张琦教授说，通过这种合作关系，我们的目标是利用我们的集体专业知识，为世界各地的个人提供最高质量的NAD+产品，支持他们改善健康和活力的旅程。。

About NADclinic Group

关于NADclinic Group

NADclinic Group are purveyors of NAD+ therapeutics, NAD+ supplements, and diagnostics. The NADclinic brand is trademarked internationally, including in the US, and internationally recognised as a leader in NAD product innovation. Currently, NADclinic cooperates with 30+ leading clinical brands across the globe, with their trademark protocol menu being uniformly adopted by all preferred partners.

NADclinic Group是NAD+疗法，NAD+补充剂和诊断的供应商。NADclinic品牌在包括美国在内的国际上都有商标，在国际上被公认为NAD产品创新的领导者。目前，NADclinic与全球30多个领先的临床品牌合作，其商标协议菜单被所有首选合作伙伴统一采用。

The NADclinic brand is now active in 40 countries across five continents. NADclinic continues to innovate and develop the brand internationally, expanding their presence within the wellness, medical, and top-tier hospitality sectors. NADclinic Group's ambition to become the dominant specialist NAD brand internationally, with a particular focus within the B2B and Corporate Wellness space..

NADclinic品牌目前活跃于五大洲的40个国家。NADclinic继续在国际上创新和发展该品牌，扩大其在健康、医疗和顶级酒店行业的影响力。NADclinic Group的目标是成为国际上占主导地位的NAD专业品牌，特别关注B2B和企业健康领域。。

About Bontac Bio-Engineering (Shenzhen) Co., Ltd

关于邦塔克生物工程（深圳）有限公司

Bontac Bio-Engineering (Shenzhen) Co., Ltd is a national high-tech enterprise specialising in research, development, production, and sales of biocatalysis and other synthetic biology technologies. As a pioneer in the NAD+ precursor (NMN) industry, it holds 173 international research and development patents and has globally pioneering coenzyme technology.

邦塔克生物工程（深圳）有限公司是一家专业从事生物催化和其他合成生物技术研究、开发、生产和销售的国家高新技术企业。作为NAD+前体（NMN）行业的先驱，它拥有173项国际研发专利，拥有全球领先的辅酶技术。

It is the only provincial-level coenzyme engineering technology research centre in Guangdong Province, providing a variety of NAD raw materials products including NAD ER Grade (to remove endotoxins), NAD I Grade (IVD/dietary supplements/cosmetic raw materials powder), NAD II Grade (API/intermediates), and NAD IV Grade (if higher solubility is required).

它是广东省唯一的省级辅酶工程技术研究中心，提供多种NAD原料产品，包括NAD ER级（去除内毒素），NAD I级（IVD/膳食补充剂/化妆品原料粉），NAD II级（API/中间体）和NAD IV级（如果需要更高的溶解度）。

These are widely used in nutritional health, biomedicine, medical aesthetics, daily chemical products, green agriculture, and other fields..

这些产品广泛应用于营养保健、生物医学、医学美学、日化产品、绿色农业等领域。。